Trademark: 86837934
Word
THINC COGNITION IN DEPRESSION
Status
Dead
Status Code
601
Status Date
Tuesday, June 14, 2016
Serial Number
86837934
Mark Type
3000
Filing Date
Thursday, December 3, 2015
Abandoned Date
Monday, June 13, 2016

Trademark Owner History

Classifications
5 Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, oncology, pain, alcoholism and dependency; medical diagnostic preparations for medical purposes, reagents for medical use, diagnostic agents preparations and substances for medical purposes
10 Surgical and medical apparatus and instruments; apparatus and instruments for diagnostic purposes including test kits; integrated medical systems containing medical instruments and software for information and information management for use of a Web-based physical and psychological and neurological examination and assessment of patients and clients at a distance and at a clinic; medical instruments for information, guidance and control of medicines
41 Education services, namely, providing continuing medical education courses; providing of training, namely, medical training and teaching; arranging and conducting educational seminars, conferences, symposiums, workshops, training and courses in the field of medicine; educational classes, courses, seminars and workshops and training services in the field of research and development for the treatment and prevention of brain and central nervous system diseases and disorders, science, clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; educational services, namely, seminars, conferences, symposiums, workshops, training and courses and training services in the field of medical research and development, science, clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention of disease provided electronically, on-line, via the Internet and global communications networks; education services, namely, arranging and conducting of expert forums, in the form of seminars, conferences, symposia, workshops and courses in the field of medicine; educational services, namely, providing medical training online; providing non-downloadable, on-line publications, namely, books, reports, brochures, booklets, leaflets, including patient information leaflets, magazines, journals, teaching and educational material in the nature of articles, journals in the field of medical research and development, science, clinical tests and trials, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention of disease
44 Medical services in the field of psychiatry and psychology, namely, medical advice related to medical and pharmaceutical preparations and substances; medical clinical services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; medical treatment services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; therapeutic treatment services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; therapeutic clinical services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; healthcare and medical services related to central nervous system and brain disorders, diseases and pharmaceuticals; providing information relating to diagnostic and therapeutic properties of pharmaceuticals in the field of disorders, diseases, treatment and prevention; providing medical information services; providing on-line medical data and analyses designed to provide patients and clients customized information, including medical dose, diagnosis, therapeutic issues and medical management
The color(s) blue and red is/are claimed as a feature of the mark.
The mark consists of the stylized wording THINC in blue to the left of a red thought cloud above the stylized words COGNITION IN DEPRESSION in red.
THINK COGNITION IN DEPRESSION

Trademark Events
Jun 14, 2016
Abandonment Notice Mailed - Express Abandonment
Jun 14, 2016
Abandonment - Express Mailed
Jun 13, 2016
Teas Express Abandonment Received
Mar 30, 2016
Notification Of Non-Final Action E-Mailed
Mar 30, 2016
Non-Final Action E-Mailed
Mar 30, 2016
Non-Final Action Written
Mar 22, 2016
Assigned To Examiner
Dec 9, 2015
Notice Of Design Search Code And Pseudo Mark E-Mailed
Dec 8, 2015
New Application Office Supplied Data Entered In Tram
Dec 7, 2015
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24